DeciBio Insights

DeciBio Analytics Launches 2021 DxBooks Databases

DeciBio Analytics has launched three 2021 DxBooks databases, covering U.S. labs’ testing
behaviors in the areas of oncology biomarkers, infectious disease diagnostics, and SARS-CoV-2
testing. These databases, purchased in 2019 from the Emmes Group and formerly known as the
Emmes Databases, cover over a thousand hospital, reference, and public health labs.

Each database offers detailed quantitative and qualitative information about labs’ test
adoption, kits and platforms used, volumes, trends, and more. Historical data going back up to
five years offers further opportunity to track changes in the relevant markets over time.
Intuitive browser-accessible Tableau interfaces complement delivery of the raw data to
facilitate point-and-click custom data slicing and quick insights.

The flagship Infectious Disease DxBook includes 31 analytes (both single-target and panels),
1,000 U.S. labs, and has data available going back to 2016. The Oncology DxBook covers 26
oncology biomarkers across 300 institutions; historical data is available since 2017. Finally, the
SARS-CoV-2 DxBook, newly launched in 2020, offers twice-annual interviews at 400 U.S. labs,
covering diagnostic and serology testing practices as well as expectations for the future of the

“These databases have been a valuable tool for our subscriber clients as well as for DeciBio’s
bespoke strategic consulting practice. We’ve seen clients make great use of this data for sales
and marketing, portfolio prioritization, product development, and other uses across the
diagnostics space,” says David Cavanaugh, a DeciBio Consulting founding partner.

“This simultaneous rebrand and re-launch maintains the same level of high-quality data
collection that our clients have relied on for years, while bringing the product identity fully into
the DeciBio suite of data and consulting offerings,” notes Julia Daniel, product manager for the
DxBooks databases. The databases are available off-the-shelf on an annual subscription basis or
as part of the custom strategic consulting projects DeciBio is known for.

For more information about the DxBooks databases, contact [email protected]



BioTrack is the all-in-one data aggregator for busy life science professionals.
Discover the latest life science news, publications, and clinical trials.

Julia Daniel | Product Manager

Julia is the product manager for DeciBio’s DxBooks databases, which capture detailed, up-to-date diagnostic testing behaviors from hundreds of labs across the U.S. Her strategic consulting experience at DeciBio has focused on clinical diagnostics, health technology, and the infectious disease space. Connect with her on LinkedIn or reach out at [email protected].

Disclaimer: Companies listed above may be DeciBio clients and/or customers.